Related Experiment Video
Updated: Apr 30, 2026
06:16
Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
6.8K
Pharmacokinetics considerations for gout treatments
Pascal Richette1, Aline Frazier, Thomas Bardin
1Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine , F-75205 Paris , France.
Expert Opinion on Drug Metabolism & Toxicology
|May 10, 2014
Summary
Understanding gout drug pharmacokinetics is crucial due to common comorbidities. This review details drug interactions and dosing adjustments for colchicine, canakinumab, allopurinol, febuxostat, and pegloticase.
Area of Science:
- Pharmacology
- Nephrology
- Rheumatology
Background:
- Gout frequently co-occurs with renal failure, cardiovascular disease, and metabolic syndrome.
- Comorbidities complicate gout management and necessitate careful drug selection.
- Understanding drug pharmacokinetics is essential for effective gout treatment.
Purpose of the Study:
- To review the pharmacokinetics of key gout medications.
- To highlight potential drug interactions and toxicity concerns.
- To provide guidance on drug selection and dosing in patients with comorbidities.
Main Methods:
- A comprehensive literature search of MEDLINE/PubMed was conducted.
- Articles published in English from January 1990 to January 2014 were included.
- Search terms included specific gout medications, pharmacokinetics, toxicity, and drug interactions.
Main Results:
- Colchicine has a narrow therapeutic window; avoid co-prescription with strong CYP3A4 or P-glycoprotein inhibitors.
- Canakinumab offers an alternative for patients with contraindications to other gout treatments.
- Allopurinol dosage adjustment based on creatinine clearance is recommended for renal impairment; febuxostat is suitable for mild-to-moderate renal failure.
Conclusions:
- Pharmacokinetic knowledge is vital for managing gout in patients with comorbidities.
- Drug interactions and patient-specific factors (e.g., renal function) significantly influence treatment choices.
- Careful consideration of pharmacokinetics ensures optimal therapeutic outcomes and minimizes toxicity.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
354
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
371
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
371
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
357
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
357
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
665
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
665
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379